Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04021914 · ClinicalTrials.gov registry record · NA
Feasibility of EnChroma Use in the Emergency Department Setting
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04021914: Clinical Trial NA study, sponsored by Emory University.
NCT04021914 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04021914, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study addresses whether the use of EnChroma products are feasible for use in the emergency department by color vision deficient providers.
Primary Outcome
Subjective influence of EnChroma glasses will be assessed by asking to describe a difference that the glasses made in color vision. The overall quality of color perception will be assessed with a scale from 1 to 10. Higher score correlates highest quality (better outcome).
Interventions
- DEVICE EnChroma glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
Why NCT04021914 stopped before completion
NCT04021914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which EnChroma glasses is the first listed.
NCT04021914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04021914 about?
NCT04021914 is a clinical study titled "Feasibility of EnChroma Use in the Emergency Department Setting". This study addresses whether the use of EnChroma products are feasible for use in the emergency department by color vision deficient providers.
What is the current status of trial NCT04021914?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2019-08-14. Estimated completion is 2023-03-15.
What interventions are being tested in trial NCT04021914?
The interventions under investigation include: EnChroma glasses (DEVICE).
Who is sponsoring clinical trial NCT04021914?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04021914's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI